ArticleCureus2025
Therapeutic Electrical Stimulation Using Belt Electrodes and Nutritional Management in a Patient With Rheumatoid Arthritis and Sarcopenia: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Patients with sarcopenia are recommended to undergo rehabilitation treatment consisting of resistance training and nutritional management. However, resistance training in patients with rheumatoid arthritis (RA) remains controversial because it may exacerbate joint impairments. Wide-area, low-pain therapeutic electrical stimulation (TES) using belt electrodes is a novel method that induces whole-muscle contractions in the lower limbs and has been increasingly adopted in clinical settings. This report describes a patient with concurrent RA and sarcopenia who underwent combined TES and nutritional management to assess its feasibility and efficacy. The patient was a 73-year-old woman who had been diagnosed with RA over one year ago, had initiated medication, and had low disease activity. As the patient had both RA and sarcopenia, a rehabilitation treatment combining novel TES and nutritional management was implemented over a six-month period. The patient underwent TES for 20 minutes once or twice a week as an outpatient. In addition, she was instructed to drink one nutritional supplemental drink containing the essential amino acid leucine daily at home. No joint-related adverse events occurred during the rehabilitation treatment, and the patient consumed the nutritional supplemental drink with high adherence. After six months, the patient's muscle mass and strength had increased and physical performance had improved, suggesting that combined TES and nutritional management may be a feasible, safe, and effective strategy for treating sarcopenia in patients with RA. Many patients with RA only receive limited outpatient rehabilitation treatment. Our program combining TES and nutritional management as an alternative to resistance training may represent an important strategy to treat sarcopenia in patients with RA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.